Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...
Same-store sales in the country grew 5%, outpacing the broader QSR market. It also benefited immensely from the launch of other innovative menu items like Secret Aardvark fries and Cheez-It. Yum!